$0.95
3.30%
Nasdaq, Sep 02, 10:02 pm CET
ISIN
US26745T1016
Symbol
DYAI

Dyadic International, Inc. Stock price

$0.95
-0.06 5.77% 1M
-0.45 32.02% 6M
-0.80 45.62% YTD
-0.39 28.98% 1Y
-1.65 63.40% 3Y
-6.88 87.85% 5Y
-0.03 2.89% 10Y
-1.58 62.38% 20Y
Nasdaq, Closing price Tue, Sep 02 2025
+0.03 3.30%
ISIN
US26745T1016
Symbol
DYAI
Industry

Key metrics

Basic
Market capitalization
$34.4m
Enterprise Value
$34.5m
Net debt
$20.0k
Cash
$5.0m
Shares outstanding
30.1m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
8.3 | 7.3
EV/Sales
8.3 | 7.3
EV/FCF
negative
P/B
negative
Financial Health
Equity Ratio
24.9%
Return on Equity
-235.2%
ROCE
-121.1%
ROIC
-
Debt/Equity
-9.4
Financials (TTM | estimate)
Revenue
$4.1m | $4.7m
EBITDA
- | -
EBIT
$-5.4m | $-6.2m
Net Income
$-5.6m | $-5.2m
Free Cash Flow
$-3.0m
Growth (TTM | estimate)
Revenue
128.7% | 34.1%
EBITDA
- | -
EBIT
32.5% | -5.8%
Net Income
27.9% | 10.0%
Free Cash Flow
50.0%
Margin (TTM | estimate)
Gross
59.9%
EBITDA
- | -
EBIT
-131.2%
Net
-134.8% | -111.4%
Free Cash Flow
-72.0%
More
EPS
$-0.2
FCF per Share
$-0.1
Short interest
0.2%
Employees
6
Rev per Employee
$580.0k
Show more

Is Dyadic International, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.

Dyadic International, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Dyadic International, Inc. forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a Dyadic International, Inc. forecast:

Buy
86%
Hold
14%

Financial data from Dyadic International, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
4.14 4.14
129% 129%
100%
- Direct Costs 1.66 1.66
82% 82%
40%
2.48 2.48
176% 176%
60%
- Selling and Administrative Expenses 5.77 5.77
9% 9%
139%
- Research and Development Expense 2.13 2.13
18% 18%
51%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT -5.42 -5.42
33% 33%
-131%
Net Profit -5.58 -5.58
28% 28%
-135%

In millions USD.

Don't miss a Thing! We will send you all news about Dyadic International, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Dyadic International, Inc. Stock News

Neutral
Seeking Alpha
20 days ago
Dyadic International, Inc. (NASDAQ:DYAI ) Q2 2025 Earnings Conference Call August 13, 2025 5:00 PM ET Company Participants Joseph P. Hazelton - President & COO Mark A.
Neutral
GlobeNewsWire
20 days ago
JUPITER, Fla., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on the scalable production of high-value, precision engineered functional input proteins for non-therapeutic applications in life sciences, food and nutrition, and industrial biotechnology utilizing its proprietary gen...
Neutral
GlobeNewsWire
28 days ago
JUPITER, Fla., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (Nasdaq: DYAI), a global biotechnology company focused on the scalable production of high-value, precision engineered functional input proteins for use in life sciences, food and nutrition, and industrial biotechnology applications utilizing its proprietary gene expression...
More Dyadic International, Inc. News

Company Profile

Dyadic International, Inc. engages in developing a gene expression platform for producing commercial quantities of industrial enzymes and other proteins. It focuses on further improving and applying its proprietary C1 technology, which is used in the discovery, development, and manufacture of biologic medicines and vaccines. The company was founded by Mark A. Emalfarb in 1979 and is headquartered in Jupiter, FL.

Head office United States
CEO Mark Emalfarb
Employees 6
Founded 1979
Website dyadic.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today